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Purpose: Symptoms of urinary bladder detrusor dysfunction have been rarely reported in Lyme disease. The aim was to carry 
out the first systematic study to compare the prevalence of such symptoms in a group of Lyme disease patients and a group of 
matched controls.
Methods: A questionnaire relating to detrusor function was administered to 17 serologically positive Lyme disease patients and 
to 18 control subjects.
Results: The two groups were matched in respect of age, sex, body mass, and mean arterial blood pressure. None of the 35 subjects 
was taking medication which might affect urinary function and none had undergone a previous operative procedure on the lower 
urinary tract. Six of the Lyme patients (35%) and none of the controls (0%) had symptoms of detrusor dysfunction (P<0.01).
Conclusions: This first systematic controlled study confirms that Lyme disease is associated with urinary bladder detrusor dys-
function. Further evaluation of detrusor function is warranted in this disease.
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INTRODUCTION
Lyme disease or Lyme borreliosis is a systemic arthropod-borne 
zoonosis caused by Borrelia spirochaetes, the incidence of which 
has recently been increasing with the geographical spread of in-
fected ticks. It is well established that the bacteria can invade 
the skin (causing erythema migrans), musculoskeletal system 
(giving rise to Lyme arthritis), cardiovascular system (causing 
Lyme carditis), and the nervous system (Lyme neuroborrelio-
sis) [1]. 
 There are rare reports that Lyme disease may also affect the 
urinary bladder. A study of chronic neurological manifestations 
of erythema migrans in 44 patients seen between 1985 and 1987 
in the Federal Republic of Germany (West Germany) reported 
that 11 of these patients (25%) suffered from ‘bladder dysfunc-
tion’; no further details were given of the symptoms associated 
with this [2]. In 1990, Chancellor et al. [3] reported a case of 
Lyme disease presenting with urinary retention; the patient 
then went on to suffer lower extremity paralysis, and both the 
urinary retention and the paralysis responded to intravenous 
ceftriaxone therapy. Three years later, Chancellor et al. [4] de-
scribed a series of seven patients with neuroborreliosis who also 
suffered from lower urinary tract dysfunction. Finally, last year 
Kim et al. [5] reported a case of neurogenic bladder in Lyme 
neuroborreliosis, which did not respond to intravenous ceftri-
axone. These two case reports and two case series were not con-
trolled.
 The aim was to carry out the first systematic study to com-
pare the prevalence of symptoms of urinary bladder detrusor 
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This study was cross-sectional and carried out in the Breakspear 
neuroscience department. Serologically positive Lyme disease 
patients who were undergoing routine clinical investigations 
and normal controls were assessed with respect to medication, 
past medical history, body mass, and arterial blood pressure. 
Exclusion criteria included: taking medication which could af-
fect urinary bladder function, such as diuretics, calcium chan-
nel blockers, alpha-adrenergic antagonists, antipsychotics, tri-
cyclic antidepressants, selective serotonin re-uptake inhibitors, 
muscle relaxants, opioids and theophylline; a history of past op-
erative procedures on the lower urinary tract, including sphinc-
terotomy, transurethral resection of the prostate and urethro-
pexy; and a history of spinal or pelvic operations which might 
affect bladder function.
 Written informed consent was obtained and a Research Eth-
ics Committee approved the study, which was carried out in ac-
cordance with the Declaration of Helsinki.
Assessment of Detrusor Dysfunction Symptoms
Detrusor function was assessed by asking all subjects the ques-
tions shown in Table 1. An affirmative answer to the first three 
questions or an answer to the fifth answer consistent with noc-
turia was taken as symptomatic of detrusor dysfunction.
Statistical Analysis
Continuous variables for which data which did not differ sig-
nificantly from normality and for which the two groups did not 
have significantly different variances were compared between 
the Lyme disease and control groups using independent sam-
ples t-tests (equal variances), while the discrete nominal vari-
ables were compared between groups using Fisher exact proba-
bility test. All tests were two-tailed. The software package IBM 
SPSS ver. 20.0 (IBM Co., Armonk, NY, USA) was used for the 
statistical analyses.
RESULTS
Seventeen serologically positive Lyme disease patients and 18 
control subjects were studied. The mean age, sex ratio, mean 
body mass, and mean arterial blood pressure for each group are 
shown in Table 2, from which it can be seen that the two groups 
were matched in respect of all these parameters.
 Six of the Lyme disease group (35%) had symptoms of detru-
sor dysfunction compared with none (0%) of the controls 
(Fisher exact probability test, P=0.008).
DISCUSSION
This first systematic controlled study confirms that Lyme dis-
ease is associated with urinary bladder detrusor dysfunction. 
That the prevalence in the present study was over a third indi-
cates that it is important that urological complications of Lyme 
disease be checked for in patients with this infection.
 Further urological studies in Lyme disease are warranted, in-
cluding assessment of the prevalence of detrusor dysfunction in 
larger sample sizes and laboratory evaluation of urinary bladder 
function by urodynamic studies. Studies also need to be carried 
out to evaluate the response to antibiotic therapy.
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Arterial blood pressure 
(mmHg)
74.3 (4.2) 66.9 (4.4) 0.234
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